DBeQ

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameDBeQ
Drug Alias NameDBeQ
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTransitional endoplasmic reticulum ATPase inhibitors
TargetsTransitional endoplasmic reticulum ATPase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCalifornia Institute Of Technology
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCalifornia Institute Of Technology
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A